🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Renaissance Technologies (RenTech)’s PRTA Holdings & Trades

First Buy
Q4 2013
Duration Held
41 Quarters
Largest Add
Q2 2020
+303,062 Shares
Current Position
607,515 Shares
$5.91 M Value

Renaissance Technologies (RenTech)'s PRTA Position Overview

Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 607,515 shares of Prothena Corporation plc (PRTA) worth $5.91 M, representing 0.01% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 41 quarters.

Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in PRTA, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 303,062 shares. Largest reduction occurred in Q4 2022, reducing 162,000 shares.

Analysis based on 13F filings available since 2013 Q2

Renaissance Technologies (RenTech)'s Prothena Corporation plc (PRTA) Holding Value Over Time

Track share changes against reported price movement

Quarterly Prothena Corporation plc (PRTA) Trades by Renaissance Technologies (RenTech)

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 +172,000 Add 39.49% 607,515 $9.72
Q4 2025 +64,215 Add 17.29% 435,515 $9.55
Q3 2025 +281,100 Add 311.64% 371,300 $9.76
Q2 2025 -149,700 Reduce 62.40% 90,200 $6.07
Q1 2025 +38,000 Add 18.82% 239,900 $12.38
Q4 2024 +19,100 Add 10.45% 201,900 $13.85
Q3 2024 -146,700 Reduce 44.52% 182,800 $16.73
Q2 2024 -60,200 Reduce 15.45% 329,500 $20.64
Q1 2024 +53,900 Add 16.05% 389,700 $24.77
Q4 2023 +75,200 Add 28.86% 335,800 $36.34
Q3 2023 -63,200 Reduce 19.52% 260,600 $48.25
Q2 2023 -83,500 Reduce 20.50% 323,800 $0.07
Q1 2023 -67,600 Reduce 14.23% 407,300 $0.05
Q4 2022 -162,000 Reduce 25.44% 474,900 $0.06
Q3 2022 -49,100 Reduce 7.16% 636,900 $60.63
Q2 2022 +291,800 Add 74.02% 686,000 $27.15
Q1 2022 +127,400 Add 47.75% 394,200 $36.57
Q4 2021 +9,600 Add 3.73% 266,800 $49.40
Q3 2021 +18,900 Add 7.93% 257,200 $71.23
Q2 2021 -50,700 Reduce 17.54% 238,300 $51.41
Q1 2021 -25,000 Reduce 7.96% 289,000 $25.12
Q4 2020 +48,800 Add 18.40% 314,000 $12.01
Q3 2020 -122,762 Reduce 31.64% 265,200 $9.99
Q2 2020 +303,062 Add 356.96% 387,962 $10.46
Q1 2020 +15,800 Add 22.87% 84,900 $10.69
Q4 2019 +24,100 Add 53.56% 69,100 $15.83
Q3 2019 +45,000 New Buy 45,000 $7.84
Q2 2019 -12,800 Sold Out 0 $0.00
Q1 2019 +12,800 New Buy 12,800 $12.11
Q4 2018 -57,400 Sold Out 0 $0.00
Q3 2018 +57,400 New Buy 57,400 $13.08
Q1 2018 -42,700 Sold Out 0 $0.00
Q4 2017 +42,700 New Buy 42,700 $37.49
Q1 2016 -90,600 Sold Out 0 $0.00
Q4 2015 +54,200 Add 148.90% 90,600 $68.11
Q3 2015 +36,400 New Buy 36,400 $45.33
Q4 2014 -17,300 Sold Out 0 $0.00
Q3 2014 -34,600 Reduce 66.67% 17,300 $22.14
Q2 2014 -27,212 Reduce 34.40% 51,900 $22.54
Q1 2014 +14,512 Add 22.46% 79,112 $38.31
Q4 2013 +64,600 New Buy 64,600 $26.52

Renaissance Technologies (RenTech)'s Prothena Corporation plc Investment FAQs

Renaissance Technologies (RenTech) first purchased Prothena Corporation plc (PRTA) in Q4 2013, acquiring 64,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Renaissance Technologies (RenTech) has held Prothena Corporation plc (PRTA) for 41 quarters since Q4 2013.

Renaissance Technologies (RenTech)'s largest addition to Prothena Corporation plc (PRTA) was in Q2 2020, adding 387,962 shares worth $4.06 M.

According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 607,515 shares of Prothena Corporation plc (PRTA), valued at approximately $5.91 M.

As of the Q1 2026 filing, Prothena Corporation plc (PRTA) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.

Renaissance Technologies (RenTech)'s peak holding in Prothena Corporation plc (PRTA) was 686,000 shares, as reported at the end of Q2 2022.